DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$7,568,000
-22.3%
1,291,531
+68.7%
0.31%
-1.6%
Q1 2015$9,744,000
-41.8%
765,450
-35.3%
0.32%
-47.5%
Q4 2014$16,746,000
-37.0%
1,183,484
-38.8%
0.60%
-37.9%
Q3 2014$26,585,000
-55.5%
1,933,484
-50.2%
0.97%
-59.7%
Q2 2014$59,742,000
+149.9%
3,884,409
+176.8%
2.40%
+146.1%
Q1 2014$23,909,000
+24.5%
1,403,105
-5.4%
0.98%
-1.9%
Q4 2013$19,208,000
-50.5%
1,483,260
-61.5%
1.00%
-44.9%
Q3 2013$38,839,000
-11.3%
3,849,296
-34.4%
1.81%
-12.5%
Q2 2013$43,809,0005,864,6122.06%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$30.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders